Overview
Alvita Vilkeviciute practices practicing medicine in Kaunas, Lithuania.
Ms. Vilkeviciute is highly rated in 6 conditions, according to our data. Her clinical expertise encompasses Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Hypothalamic Tumor, and Pituitary Tumor.
She is actively involved in clinical research, co-authoring 78 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Alvita Vilkeviciute
Is Alvita Vilkeviciute a top-rated expert for Age-Related Macular Degeneration (ARMD)?
MediFind is an objective health platform that identifies experts based on real-world data. Alvita Vilkeviciute is classified as an Distinguished expert for Age-Related Macular Degeneration (ARMD), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Alvita Vilkeviciute participate in research or clinical trials?
Yes. Alvita Vilkeviciute has published 78 articles and abstracts on conditions like Age-Related Macular Degeneration (ARMD). You can view a list of Alvita Vilkeviciute's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Age-Related Macular Degeneration (ARMD)Ms. Vilkeviciute isDistinguished. Learn about Age-Related Macular Degeneration (ARMD).
- Late-Onset Retinal DegenerationMs. Vilkeviciute isDistinguished. Learn about Late-Onset Retinal Degeneration.
- Advanced
- Hypothalamic TumorMs. Vilkeviciute isAdvanced. Learn about Hypothalamic Tumor.
- Laryngeal CancerMs. Vilkeviciute isAdvanced. Learn about Laryngeal Cancer.
- Pituitary TumorMs. Vilkeviciute isAdvanced. Learn about Pituitary Tumor.
- Throat CancerMs. Vilkeviciute isAdvanced. Learn about Throat Cancer.
- Experienced
- Brain TumorMs. Vilkeviciute isExperienced. Learn about Brain Tumor.
- Ganglion CystMs. Vilkeviciute isExperienced. Learn about Ganglion Cyst.
- Head and Neck Squamous Cell Carcinoma (HNSCC)Ms. Vilkeviciute isExperienced. Learn about Head and Neck Squamous Cell Carcinoma (HNSCC).
- Leber Hereditary Optic Neuropathy (LHON)Ms. Vilkeviciute isExperienced. Learn about Leber Hereditary Optic Neuropathy (LHON).
- Multiple Sclerosis (MS)Ms. Vilkeviciute isExperienced. Learn about Multiple Sclerosis (MS).
- NearsightednessMs. Vilkeviciute isExperienced. Learn about Nearsightedness.
- Optic Nerve AtrophyMs. Vilkeviciute isExperienced. Learn about Optic Nerve Atrophy.
- Optic NeuritisMs. Vilkeviciute isExperienced. Learn about Optic Neuritis.